From July 13 to 15 and July 19, 2022, the PMDA held a four-day online seminar entitled “PMDA-ATC Pharmaceuticals Review Webinar for JICA trainees 2022”, with the Japan International Cooperation Agency (JICA). Eight people from seven countries/regions (Bhutan, Indonesia, Iraq, Laos, North Macedonia, Samoa, and Timor-Leste) participated in the webinar. Before attending the live webinar, the participants studied E-learning materials covering topics such as the overview of the PMDA, approval review in Japan, approval review of generic drugs, safety measures, GMP inspections, pharmaceutical administration in local governments, etc. In the online live webinar, participants had Q&A sessions with lecturers from the PMDA, Ministry of Health, Labour and Welfare (MHLW), and Pharmaceutical Policy Division at the Health and Welfare Department of Toyama Prefectural Government.
Back
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
International Activities
Safety Information
Advanced Efforts
-
Information for approved products in Japan
Safety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
-
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
Advanced efforts
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Reviews and Related Services
Regulatory Procedures
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety
Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC Pharmaceuticals Review Webinar for JICA trainees 2022
Events and Symposia